Phillies’ Johan Rojas faces a double setback after UCL injury ends 2026 return attempt

Johan Rojas’ attempt to get back on the field with the Philadelphia Phillies has run into a second, major complication. Rojas is still serving an 80-game suspension for a PED-related offense, but the team also announced that, during his preparation to return from the ban, he suffered a UCL injury. The injury is now expected to keep him out for the rest of the 2026 season, turning what was already a delayed timeline into an extended absence.

For the Phillies, the immediate problem is roster math. Rojas’ suspension created a gap in the outfield mix that Philadelphia had planned to address with internal options. Now, with his return postponed indefinitely due to the UCL issue, the club’s near-term plans for outfield depth and playing time are likely to shift again, especially with the long grind of a full MLB calendar that does not pause for a single player’s recovery schedule.

The double setback also raises questions about how Rojas fits into the Phillies’ wider evaluation picture. Before this season’s disruption, Rojas’ role would have been shaped by his ability to contribute as an outfielder and provide value in a variety of game states. With both the suspension and a season-ending injury removing him from meaningful action, the organization loses time to assess his performance and readiness, and it may have to lean more heavily on other players whose chances on the field will expand in his absence.

The timing of the UCL injury is notable, even without added medical detail. A UCL issue typically involves the elbow, and while position players do not always face the same kind of rehab timeline as pitchers, an injury in that region can still reduce throwing ability and overall on-field readiness. According to the report, the injury occurred while Rojas was preparing to return from the PED-related suspension, meaning he was already in a transition period between being unavailable and being ready to compete. That makes the setback particularly impactful for a player working back toward a precise return window.

Philly’s decision-making going forward will likely focus on two tracks at once: who absorbs the playing time Rojas was expected to reclaim, and how the Phillies manage the returning-to-health pipeline once Rojas eventually begins a fuller rehab process. In the short term, the club’s outfield depth and bench options become more important, because late-season roster flexibility often depends on who can play regularly and who can be deployed across multiple matchups.

The broader competitive context matters too. Without Rojas for the rest of 2026, the Phillies must account for the loss of both his immediate contributions and his possible midseason impact. Whether Philadelphia is chasing a playoff position or managing variance across the roster, the absence of a player tied to the organization’s mid-level planning can alter lineup construction and leverage how often managers turn to the same alternatives.